Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System
暂无分享,去创建一个
G. Jacob | B. Brenner | Benjamin Brenner | Galit Sarig | Giris Jacob | G. Sarig | Muhannad Masoud | M. Masoud | Muhannad Masoud
[1] J. Dormandy. Clinical significance of blood viscosity. , 1970, Annals of the Royal College of Surgeons of England.
[2] Dormandy Ja. Clinical significance of blood viscosity. , 1970 .
[3] S. Horvath,et al. Plasma volume changes with movement to supine and standing positions. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.
[4] L V McIntire,et al. Characteristics of shear-induced aggregation in whole blood. , 1984, The Journal of laboratory and clinical medicine.
[5] McIntire Lv,et al. Characteristics of shear-induced aggregation in whole blood. , 1984 .
[6] M. Moser,et al. Fluid and protein shifts after postural changes in humans. , 1986, The American journal of physiology.
[7] E. Bassenge,et al. Endothelial function in different organs. , 1996, Progress in cardiovascular diseases.
[8] P. Norsk,et al. Adaptation of plasma volume in humans to prolonged head-down bed rest. , 1996, Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology.
[9] P. Persson. Modulation of cardiovascular control mechanisms and their interaction. , 1996, Physiological reviews.
[10] S. Chien,et al. Shear stress induction of the tissue factor gene. , 1997, The Journal of clinical investigation.
[11] F. Dati,et al. ProC Global: the first functional screening assay for the complete protein C pathway. , 1997, Clinical chemistry.
[12] G. Remuzzi,et al. Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. , 1997, Blood.
[13] R Furlan,et al. Effect of standing on neurohumoral responses and plasma volume in healthy subjects. , 1998, Journal of applied physiology.
[14] S. Nakamura,et al. Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells. , 1998, Thrombosis research.
[15] J. Muller,et al. Upright posture and maximal exercise increase platelet aggregability and prostacyclin production in healthy male subjects. , 1999, British journal of sports medicine.
[16] W. Aird,et al. Vascular-bed--specific hemostasis and hypercoagulable states. , 1999, The New England journal of medicine.
[17] Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values. , 1999, Archives of internal medicine.
[18] M. Hitosugi,et al. Rheologic changes in venous blood during prolonged sitting. , 2000, Thrombosis research.
[19] C. Wollheim,et al. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. , 2000, The Journal of clinical investigation.
[20] J. Hathcock,et al. Active tissue factor shed from human arterial smooth muscle cells adheres to artificial surfaces , 2000, Journal of biomaterials science. Polymer edition.
[21] P. Toulon,et al. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism. , 2001, Thrombosis research.
[22] D. Monroe,et al. A Cell-based Model of Hemostasis , 2001, Thrombosis and Haemostasis.
[23] F Lapostolle,et al. Severe pulmonary embolism associated with air travel. , 2001, The New England journal of medicine.
[24] L. Mazzolai,et al. Tissue Factor Activity Is Upregulated in Human Endothelial Cells Exposed to Oscillatory Shear Stress , 2002, Thrombosis and Haemostasis.
[25] R. Hoffman,et al. Protein C Global Assay in the Evaluation of Women with Idiopathic Pregnancy Loss , 2002, Thrombosis and Haemostasis.
[26] Tsung O Cheng,et al. Could elevated C-reactive protein in patients with obstructive sleep apnea be due to obesity per se? , 2003, Circulation.
[27] G. Lip,et al. Virchow’s Triad Revisited: Blood Constituents , 2003, Pathophysiology of Haemostasis and Thrombosis.
[28] A. Lee,et al. Epidemiology and management of venous thromboembolism in patients with cancer. , 2003, Thrombosis research.
[29] J. Heit,et al. Risk factors for venous thromboembolism. , 2003, Clinics in chest medicine.
[30] W. Schobersberger,et al. Coagulation changes and edema formation during long-distance bus travel , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[31] A. Kroon,et al. The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems. , 2005, Hypertension.
[32] G. Lip,et al. Endothelial function and its assessment , 2005, Expert opinion on investigational drugs.
[33] A. Ertl,et al. Postural pseudoanemia: posture-dependent change in hematocrit. , 2005, Mayo Clinic proceedings.
[34] C. Keenan,et al. Age as a risk factor for venous thromboembolism after major surgery , 2005, Current opinion in pulmonary medicine.
[35] F. Ataullakhanov,et al. Initiation and propagation of coagulation from tissue factor‐bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate * , 2005, Journal of thrombosis and haemostasis : JTH.
[36] Mikhail A Panteleev,et al. Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. , 2006, Biophysical journal.
[37] B. Mausbach,et al. The role of stress hormones in the relationship between resting blood pressure and coagulation activity , 2006, Journal of hypertension.
[38] K. Traynor. Some Medicare Part D medication management programs will use pharmacists. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[39] B. Brenner,et al. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy , 2006, Thrombosis and Haemostasis.
[40] E. Bjørklid,et al. Sources of tissue factor. , 2006, Seminars in thrombosis and hemostasis.
[41] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[42] G. Oster,et al. Risk of venous thromboembolism among hospitalized medically ill patients. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[43] P. Toulon,et al. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities , 2007, Thrombosis and Haemostasis.
[44] B. Chong,et al. Management of thromboembolism in hematologic malignancies. , 2007, Seminars in thrombosis and hemostasis.